Offerings // GYRE THERAPEUTICS, INC.

GYRE offering history

Every offering-related filing in GYRE THERAPEUTICS, INC.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 1,001 filings back to Jun 10, 2013.

Last executed offering

May 4, 2026

8-K — priced deal (shares or notes)

Last registration (announced)

Jul 13, 2026

S-3/A — capacity, not a sale

Executed, last 12 months

424B pricings + 8-K 3.02 sales

Registered, last 12 months

S-1/S-3/F-series registrations

Date	Filing		What it means
Jul 13, 2026	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Jun 23, 2026	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 4, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Mar 2, 2026	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
May 23, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 22, 2025	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 27, 2024	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Nov 22, 2024	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Nov 14, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jul 12, 2024	RW →	WITHDRAWN	Registration withdrawn
Jul 12, 2024	RW →	WITHDRAWN	Registration withdrawn
May 30, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
May 30, 2024	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 29, 2023	RW →	WITHDRAWN	Registration withdrawn
Nov 13, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Nov 1, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 30, 2023	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 27, 2023	424B3 →	UPDATE	Prospectus update — often a resale registration, not necessarily new capital
Oct 27, 2023	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Oct 24, 2023	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Oct 13, 2023	S-3/A →	REGISTERED	S-3/A registration — capacity to sell shares, not a sale yet
Jul 24, 2023	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 27, 2022	8-K →	EXECUTED	Unregistered share sale disclosed (8-K item 3.02)
Oct 15, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 3, 2021	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Mar 4, 2021	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Jan 28, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 26, 2021	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 19, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 17, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 14, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 12, 2020	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 14, 2019	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Dec 21, 2018	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Feb 14, 2018	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 12, 2018	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 6, 2018	EFFECT →	EFFECTIVE	SEC declared a registration effective — selling can begin
Jan 22, 2018	S-3 →	REGISTERED	S-3 registration — capacity to sell shares, not a sale yet
Dec 21, 2017	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 19, 2017	424B5 →	EXECUTED	Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)

GYRE offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full GYRE workspace →

GYRE offering FAQ

When did GYRE last execute an offering?

Per SEC filings, GYRE THERAPEUTICS, INC.'s most recent priced offering document is a 8-K filed 2026-05-04. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did GYRE last announce or register an offering?

The most recent registration is a S-3/A filed 2026-07-13. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.